Literature DB >> 31153706

Impact of the pattern of interstitial lung disease on mortality in rheumatoid arthritis: A systematic literature review and meta-analysis.

Namrata Singh1, Jimmy Varghese2, Bryant R England3, Joshua J Solomon4, Kaleb Michaud5, Ted R Mikuls3, Heather S Healy6, Emily M Kimpston7, Marin L Schweizer8.   

Abstract

OBJECTIVE: An important extra-articular manifestation of rheumatoid arthritis (RA) is interstitial lung disease (ILD). The relationship between the usual interstitial pneumonia (UIP) pattern and mortality in patients with RA is unclear. The purpose of this study was to complete a systematic literature review and meta-analysis on the association between RA-ILD pattern and mortality risk.
METHODS: We performed a systematic literature review through December 12, 2018. Study characteristics, unadjusted and adjusted relative risks (RR) of mortality for ILD pattern were extracted from the identified studies and quality assessments were performed. RR for mortality (RA-UIP vs. other RA-ILD) was pooled using inverse variance weighting and random effects models.
RESULTS: Ten retrospective cohort studies met our eligibility criteria. A total of 1256 RA-ILD patients were included with 484 total deaths. Meta-analysis yielded a pooled RR of 1.66 (95% confidence interval1.07 to 2.56) for death among those with UIP RA-ILD compared with other patterns. In sub-group analysis when pooling studies comparing UIP to NSIP pattern of RA-ILD, the RR was 2.39 (95% CI 0.86-6.68).
CONCLUSION: Through a systematic literature review and meta-analysis, we found UIP pattern to be associated with a higher mortality risk in RA-ILD compared to other patterns of RA-ILD although more recent studies emphasize the importance of pulmonary physiology and the extent of lung involvement as significant predictors of mortality rather than the pattern of RA-ILD. Recognizing the small number of studies satisfying eligibility and inconsistent accounting for confounders, further study of mortality risk in RA-ILD is needed with standardized assessment of various RA, ILD, and patient-related factors. Published by Elsevier Inc.

Entities:  

Keywords:  Interstitial lung disease; Rheumatoid arthritis; Usual interstitial pneumonia

Year:  2019        PMID: 31153706     DOI: 10.1016/j.semarthrit.2019.04.005

Source DB:  PubMed          Journal:  Semin Arthritis Rheum        ISSN: 0049-0172            Impact factor:   5.532


  13 in total

1.  Consensus document for the selection of lung transplant candidates: An update from the International Society for Heart and Lung Transplantation.

Authors:  Lorriana E Leard; Are M Holm; Maryam Valapour; Allan R Glanville; Sandeep Attawar; Meghan Aversa; Silvia V Campos; Lillian M Christon; Marcelo Cypel; Göran Dellgren; Matthew G Hartwig; Siddhartha G Kapnadak; Nicholas A Kolaitis; Robert M Kotloff; Caroline M Patterson; Oksana A Shlobin; Patrick J Smith; Amparo Solé; Melinda Solomon; David Weill; Marlies S Wijsenbeek; Brigitte W M Willemse; Selim M Arcasoy; Kathleen J Ramos
Journal:  J Heart Lung Transplant       Date:  2021-07-24       Impact factor: 13.569

2.  Plasma IL-36α and IL-36γ as Potential Biomarkers in Interstitial Lung Disease Associated with Rheumatoid Arthritis: a Pilot Study in the Chinese Population.

Authors:  Weishuai Zheng; Xingxing Hu; Menglin Zou; Nie Hu; Weiwei Song; Rui Wang; Ying Liu; Qinhui Hou; Yuan Liu; Xiaoqi Chen; Zhenshun Cheng
Journal:  Inflammation       Date:  2022-08-31       Impact factor: 4.657

3.  Rheumatoid arthritis-related lung disease detected on clinical chest computed tomography imaging: Prevalence, risk factors, and impact on mortality.

Authors:  Sicong Huang; Tracy J Doyle; Mark M Hammer; Suzanne C Byrne; Weixing Huang; Allison A Marshall; Christine K Iannaccone; Jie Huang; Vivi Feathers; Michael E Weinblatt; Paul F Dellaripa; Nancy A Shadick; Jeffrey A Sparks
Journal:  Semin Arthritis Rheum       Date:  2020-09-28       Impact factor: 5.532

4.  RA-ILD: does more detailed radiological classification add something to our knowledge of this condition?

Authors:  Paola Faverio; Meena Kalluri; Fabrizio Luppi; Giovanni Ferrara
Journal:  J Thorac Dis       Date:  2020-06       Impact factor: 2.895

Review 5.  Methotrexate-Associated Pneumonitis and Rheumatoid Arthritis-Interstitial Lung Disease: Current Concepts for the Diagnosis and Treatment.

Authors:  George E Fragoulis; Elena Nikiphorou; Jörg Larsen; Peter Korsten; Richard Conway
Journal:  Front Med (Lausanne)       Date:  2019-10-23

Review 6.  Monitoring and management of fibrosing interstitial lung diseases: a narrative review for practicing clinicians.

Authors:  Anoop M Nambiar; Christopher M Walker; Jeffrey A Sparks
Journal:  Ther Adv Respir Dis       Date:  2021 Jan-Dec       Impact factor: 5.158

Review 7.  Interstitial lung disease throughout the rheumatoid arthritis disease course.

Authors:  Gregory C McDermott; Tracy J Doyle; Jeffrey A Sparks
Journal:  Curr Opin Rheumatol       Date:  2021-05-01       Impact factor: 5.006

8.  Mortality rate in rheumatoid arthritis-related interstitial lung disease: the role of radiographic patterns.

Authors:  Maria A Nieto; Maria J Rodriguez-Nieto; Olga Sanchez-Pernaute; Fredeswinda Romero-Bueno; Leticia Leon; Cristina Vadillo; Dalifer D Freites-Nuñez; Juan A Jover; Jose L Álvarez-Sala; Lydia Abasolo
Journal:  BMC Pulm Med       Date:  2021-06-30       Impact factor: 3.317

Review 9.  Treatment of Rheumatoid Arthritis-Associated Interstitial Lung Disease: Lights and Shadows.

Authors:  Giulia Cassone; Andreina Manfredi; Caterina Vacchi; Fabrizio Luppi; Francesca Coppi; Carlo Salvarani; Marco Sebastiani
Journal:  J Clin Med       Date:  2020-04-10       Impact factor: 4.241

10.  Pirfenidone for the treatment of interstitial lung disease associated to rheumatoid arthritis: a new scenario is coming?

Authors:  Giulia Cassone; Marco Sebastiani; Caterina Vacchi; Stefania Cerri; Carlo Salvarani; Andreina Manfredi
Journal:  Respir Med Case Rep       Date:  2020-04-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.